logo

For the Inventor, By the Inventor

New York, NY, United States of America

Mark Morris

This inventor holds 12 USPTO granted patents and 9 published patent applications and 4 EPO patents. Top assignees: Elysium Health, Inc., Chromadex Inc., Other. Active years: 1987-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark Morris. Retrieved from https://idiyas.com/inventor/mark-morris

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 291(Granted Patents)


Location History:

  • San Francisco, CA (US) (1987 - 1989)
  • Irvine, CA (US) (2019 - 2022)
  • New York, NY (US) (2021 - 2024)

Company Filing History:

goldMedal6 out of 12 
 
Elysium Health, Inc.
 patents
silverMedal4 out of 23 
 
Chromadex Inc.
 patents
bronzeMedal2 out of 834,513 
Other
 patents

Years Active: 1987-2025

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents
1. 12433908 - Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development (2025-10-07),
2. 12128060 - Nicotinamide riboside for use in treating or preventing liver damage (2024-10-29),
3. 12043616 - Crystalline forms of nicotinamide riboside chloride (2024-07-23),
4. 11629163 - Methods of synthesizing nicotinamide riboside (2023-04-18),
5. 11524022 - Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development (2022-12-13),
6. 11414407 - Crystalline forms of nicotinamide riboside chloride (2022-08-16),
7. 11389468 - Nicotinamide riboside for use in treating or preventing liver damage (2022-07-19),
8. 11129843 - Treating and preventing kidney damage (2021-09-28),
9. 10857172 - Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development (2020-12-08),
10. 10183036 - Use of nicotinic acid riboside or nicotinamide riboside derivatives, and reduced derivatives thereof, as NAD+ increasing precursors (2019-01-22),
11. 4827923 - Protective facial mask (1989-05-09),
12. 4671271 - Protective facial mask (1987-06-09),

Title: Inventor Mark Morris - Revolutionizing Technology in New York

Introduction: Mark Morris is a visionary inventor based in New York, NY, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Mark Morris holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, Mark Morris has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have had a significant impact on various industries.

Collaborations: Throughout his career, Mark Morris has collaborated with top scientists, engineers, and researchers to bring his ideas to life, fostering a culture of innovation and excellence in all his projects.

Conclusion: Mark Morris continues to push the boundaries of technology and innovation, leaving a lasting legacy in the world of inventions and patents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…